Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.860
-0.080 (-4.12%)
At close: Jun 27, 2025, 4:00 PM
1.850
-0.010 (-0.54%)
After-hours: Jun 27, 2025, 7:55 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees decreased by 14 or -29.79% compared to the previous year.
Employees
33
Change (1Y)
-14
Growth (1Y)
-29.79%
Revenue / Employee
n/a
Profits / Employee
-$1,573,515
Market Cap
123.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MIST News
- 12 days ago - Milestone Pharmaceuticals Submits Response to the FDA's CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting - GlobeNewsWire
- 4 weeks ago - Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 3 months ago - Stock Picks From Seeking Alpha's March 2025 New Analysts - Seeking Alpha
- 3 months ago - Milestone Pharmaceuticals Shares Hit New Low After FDA Rejects Etripamil - Market Watch
- 3 months ago - US FDA declines to approve Milestone Pharma's heart rhythm nasal spray - Reuters
- 3 months ago - FDA Issues Complete Response Letter for Etripamil for PSVT - GlobeNewsWire
- 3 months ago - Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers - Seeking Alpha